Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -227,102 | -175,916 | -116,319 | -63,330 | -263,494 |
| Depreciation Amortization | 16,215 | 12,192 | 6,520 | 3,712 | 18,007 |
| Accounts receivable | 9,707 | 1,574 | 2,284 | 9,177 | 3,935 |
| Accounts payable and accrued liabilities | -292 | -3,330 | -6,454 | 8,461 | -2,791 |
| Other Working Capital | 5,533 | -6,124 | -12,193 | -8,157 | -10,887 |
| Other Operating Activity | 22,814 | 30,103 | 25,210 | -5,318 | 36,823 |
| Operating Cash Flow | $-173,125 | $-141,501 | $-100,952 | $-55,455 | $-218,407 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 105,882 | 64,530 | 13,946 | 13,740 | 200,903 |
| PPE Investments | -2,436 | -1,357 | -1,031 | -557 | -9,960 |
| Investing Cash Flow | $103,446 | $63,173 | $12,915 | $13,183 | $190,943 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 133,770 | 133,732 | 132,839 | 132,896 | 8,221 |
| Other Financing Activity | -41,087 | -33,309 | -21,559 | -12,171 | -43,187 |
| Financing Cash Flow | $92,683 | $100,423 | $111,280 | $120,725 | $-34,966 |
| Beginning Cash Position | 36,552 | 36,552 | 36,552 | 36,552 | 98,982 |
| End Cash Position | 59,556 | 58,647 | 59,795 | 115,005 | 36,552 |
| Net Cash Flow | $23,004 | $22,095 | $23,243 | $78,453 | $-62,430 |
| Free Cash Flow | |||||
| Operating Cash Flow | -173,125 | -141,501 | -100,952 | -55,455 | -218,407 |
| Capital Expenditure | -2,436 | -1,357 | -1,031 | -557 | -9,960 |
| Free Cash Flow | -175,561 | -142,858 | -101,983 | -56,012 | -228,367 |